Tocilizumab in Cardiac Transplantation
Public ClinicalTrials.gov record NCT03644667. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients With Tocilizumab (RTB-004)
Study identification
- NCT ID
- NCT03644667
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 385 participants
Conditions and interventions
Conditions
Interventions
- Placebo Biological
- Standard of Care Triple IS Drug
- tocilizumab Biological
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2018
- Primary completion
- Mar 24, 2025
- Completion
- Mar 24, 2025
- Last update posted
- Apr 6, 2026
2018 – 2025
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars Sinai Medical Center (CACS) | Beverly Hills | California | 90211 | — |
| University of California, San Diego: Sulpizio Cardiovascular Center (CASD) | La Jolla | California | 92037 | — |
| Stanford Health Care (CASU) | Stanford | California | 94305 | — |
| Tampa General Hospital (FLTG) | Tampa | Florida | 33606 | — |
| Northwestern Memorial Hospital (INLM) | Chicago | Illinois | 60611 | — |
| Tufts Medical Center (MANM) | Boston | Massachusetts | 02111 | — |
| Massachusetts General Hospital (MAMG) | Boston | Massachusetts | 02114 | — |
| St. Luke's Hospital of Kansas City (MOLH) | Kansas City | Missouri | 64111 | — |
| University of Nebraska Medical Center (NEUN) | Omaha | Nebraska | 68198 | — |
| Mount Sinai Medical Center (NYMS) | New York | New York | 10029 | — |
| Columbia University Medical Center (NYCP) | New York | New York | 10032 | — |
| Montefiore Medical Center (NYMA) | The Bronx | New York | 10467 | — |
| Duke University Medical Center (NCDU) | Durham | North Carolina | 27710 | — |
| Cleveland Clinic Foundation (OHCC) | Cleveland | Ohio | 44195 | — |
| Penn State Health: Milton S. Hershey Medical Center (PAHE) | Hershey | Pennsylvania | 17033 | — |
| Hospital of the University of Pennsylvania (PAUP) | Philadelphia | Pennsylvania | 19104 | — |
| Allegheny General Hospital (PAAG) | Pittsburgh | Pennsylvania | 15212 | — |
| Vanderbilt University Medical Center (TNVU) | Nashville | Tennessee | 37232 | — |
| Baylor University Medical Center (TXTX) | Dallas | Texas | 75246 | — |
| University of Utah (UTMC) | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03644667, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03644667 live on ClinicalTrials.gov.